From Trial to Triumph: Robyn's Pioneering CAR-T Therapy Journey
Robyn is a physician and DLBCL survivor. After relapse, she was put on the JULIET clinical trial which was one of the first CAR-T cell therapy recipients. Robyn joins HealthTree to talk about her success story on a revolutionary clinical trial.
Kat introduces the agenda and our featured speaker Robyn Stacy-Humphries
Robyn talks about her success story on a revolutionary clinical trial.
Come with your questions and we will answer them!
Kat Richardson
Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.
Robyn Stacy-Humphries
Robyn Stacy‑Humphries, MD, is a practicing radiologist from North Carolina whose life took an unexpected turn when she was diagnosed with an aggressive form of lymphoma. After experiencing multiple relapses and undergoing several lines of treatment, Robyn ultimately pursued CAR T‑cell therapy when other options were limited. Nearly a decade later, she continues to thrive—returning to full‑time work, maintaining an active lifestyle, and using her experience to support others navigating CAR T. Today, Robyn leads a global patient support community, offering guidance, reassurance, and hope to individuals and caregivers facing similar journeys. Her story highlights the resilience of patients and the transformative potential of CAR T-cell therapy.